183 related articles for article (PubMed ID: 33597881)
1. Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Do not Improve with Carnitine Supplementation.
Verkerk AO; Knottnerus SJG; Portero V; Bleeker JC; Ferdinandusse S; Guan K; IJlst L; Visser G; Wanders RJA; Wijburg FA; Bezzina CR; Mengarelli I; Houtkooper RH
Front Pharmacol; 2020; 11():616834. PubMed ID: 33597881
[TBL] [Abstract][Full Text] [Related]
2. Electrophysiological Abnormalities in VLCAD Deficient hiPSC-Cardiomyocytes Can Be Improved by Lowering Accumulation of Fatty Acid Oxidation Intermediates.
Knottnerus SJG; Mengarelli I; Wüst RCI; Baartscheer A; Bleeker JC; Coronel R; Ferdinandusse S; Guan K; IJlst L; Li W; Luo X; Portero VM; Ulbricht Y; Visser G; Wanders RJA; Wijburg FA; Verkerk AO; Houtkooper RH; Bezzina CR
Int J Mol Sci; 2020 Apr; 21(7):. PubMed ID: 32276429
[TBL] [Abstract][Full Text] [Related]
3. Non-invasive test using palmitate in patients with suspected fatty acid oxidation defects: disease-specific acylcarnitine patterns can help to establish the diagnosis.
Janzen N; Hofmann AD; Schmidt G; Das AM; Illsinger S
Orphanet J Rare Dis; 2017 Dec; 12(1):187. PubMed ID: 29268767
[TBL] [Abstract][Full Text] [Related]
4. Changes in blood carnitine and acylcarnitine profiles of very long-chain acyl-CoA dehydrogenase-deficient mice subjected to stress.
Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Exil V; Duran M; Wijburg FA; Wanders RJ; Strauss AW
Eur J Clin Invest; 2004 Mar; 34(3):191-6. PubMed ID: 15025677
[TBL] [Abstract][Full Text] [Related]
5. Tissue carnitine homeostasis in very-long-chain acyl-CoA dehydrogenase-deficient mice.
Spiekerkoetter U; Tokunaga C; Wendel U; Mayatepek E; Ijlst L; Vaz FM; van Vlies N; Overmars H; Duran M; Wijburg FA; Wanders RJ; Strauss AW
Pediatr Res; 2005 Jun; 57(6):760-4. PubMed ID: 15774826
[TBL] [Abstract][Full Text] [Related]
6. Carnitine supplementation induces acylcarnitine production in tissues of very long-chain acyl-CoA dehydrogenase-deficient mice, without replenishing low free carnitine.
Primassin S; Ter Veld F; Mayatepek E; Spiekerkoetter U
Pediatr Res; 2008 Jun; 63(6):632-7. PubMed ID: 18317232
[TBL] [Abstract][Full Text] [Related]
7. Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl-coA dehydrogenase (VLCAD) deficiency in the United States.
Miller MJ; Burrage LC; Gibson JB; Strenk ME; Lose EJ; Bick DP; Elsea SH; Sutton VR; Sun Q; Graham BH; Craigen WJ; Zhang VW; Wong LJ
Mol Genet Metab; 2015 Nov; 116(3):139-45. PubMed ID: 26385305
[TBL] [Abstract][Full Text] [Related]
8. The effect of fasting, long-chain triglyceride load and carnitine load on plasma long-chain acylcarnitine levels in mitochondrial very long-chain acyl-CoA dehydrogenase deficiency.
Costa CG; Dorland L; de Almeida IT; Jakobs C; Duran M; Poll-The BT
J Inherit Metab Dis; 1998 Jun; 21(4):391-9. PubMed ID: 9700596
[TBL] [Abstract][Full Text] [Related]
9. Remodeling of lipid landscape in high fat fed very-long chain acyl-CoA dehydrogenase null mice favors pro-arrhythmic polyunsaturated fatty acids and their downstream metabolites.
Lefort B; Gélinas R; Forest A; Bouchard B; Daneault C; Robillard Frayne I; Roy J; Oger C; Greffard K; Galano JM; Durand T; Labarthe F; Bilodeau JF; Ruiz M; Des Rosiers C
Biochim Biophys Acta Mol Basis Dis; 2023 Dec; 1869(8):166843. PubMed ID: 37558007
[TBL] [Abstract][Full Text] [Related]
10. Carnitine supplementation attenuates myocardial lipid accumulation in long-chain acyl-CoA dehydrogenase knockout mice.
Bakermans AJ; van Weeghel M; Denis S; Nicolay K; Prompers JJ; Houten SM
J Inherit Metab Dis; 2013 Nov; 36(6):973-81. PubMed ID: 23563854
[TBL] [Abstract][Full Text] [Related]
11. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
[TBL] [Abstract][Full Text] [Related]
12. Corresponding increase in long-chain acyl-CoA and acylcarnitine after exercise in muscle from VLCAD mice.
ter Veld F; Primassin S; Hoffmann L; Mayatepek E; Spiekerkoetter U
J Lipid Res; 2009 Aug; 50(8):1556-62. PubMed ID: 18980943
[TBL] [Abstract][Full Text] [Related]
13. Two siblings with very long-chain acyl-CoA dehydrogenase (VLCAD) deficiency suffered from rhabdomyolysis after l-carnitine supplementation.
Watanabe K; Yamada K; Sameshima K; Yamaguchi S
Mol Genet Metab Rep; 2018 Jun; 15():121-123. PubMed ID: 30023301
[TBL] [Abstract][Full Text] [Related]
14. Large-Scale Simulation of the Phenotypical Variability Induced by Loss-of-Function Long QT Mutations in Human Induced Pluripotent Stem Cell Cardiomyocytes.
Paci M; Casini S; Bellin M; Hyttinen J; Severi S
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30428582
[TBL] [Abstract][Full Text] [Related]
15. Metabolic Outcomes of Anaplerotic Dodecanedioic Acid Supplementation in Very Long Chain Acyl-CoA Dehydrogenase (VLCAD) Deficient Fibroblasts.
Radzikh I; Fatica E; Kodger J; Shah R; Pearce R; Sandlers YI
Metabolites; 2021 Aug; 11(8):. PubMed ID: 34436479
[TBL] [Abstract][Full Text] [Related]
16. The effects of gentamicin and penicillin/streptomycin on the electrophysiology of human induced pluripotent stem cell-derived cardiomyocytes in manual patch clamp and multi-electrode array system.
Hyun SW; Kim BR; Lin D; Hyun SA; Yoon SS; Seo JW
J Pharmacol Toxicol Methods; 2018; 91():1-6. PubMed ID: 29288713
[TBL] [Abstract][Full Text] [Related]
17. Development of appropriate fatty acid formulations to raise the contractility of constructed myocardial tissues.
Yoshida A; Sekine W; Homma J; Sekine H; Itoyama YY; Sasaki D; Matsuura K; Kobayashi E; Shimizu T
Regen Ther; 2022 Dec; 21():413-423. PubMed ID: 36248630
[TBL] [Abstract][Full Text] [Related]
18. Bezafibrate increases very-long-chain acyl-CoA dehydrogenase protein and mRNA expression in deficient fibroblasts and is a potential therapy for fatty acid oxidation disorders.
Djouadi F; Aubey F; Schlemmer D; Ruiter JP; Wanders RJ; Strauss AW; Bastin J
Hum Mol Genet; 2005 Sep; 14(18):2695-703. PubMed ID: 16115821
[TBL] [Abstract][Full Text] [Related]
19. De novo fatty acid biosynthesis and elongation in very long-chain acyl-CoA dehydrogenase-deficient mice supplemented with odd or even medium-chain fatty acids.
Tucci S; Behringer S; Spiekerkoetter U
FEBS J; 2015 Nov; 282(21):4242-53. PubMed ID: 26284828
[TBL] [Abstract][Full Text] [Related]
20. Strategies for correcting very long chain acyl-CoA dehydrogenase deficiency.
Tenopoulou M; Chen J; Bastin J; Bennett MJ; Ischiropoulos H; Doulias PT
J Biol Chem; 2015 Apr; 290(16):10486-94. PubMed ID: 25737446
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
